InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

TY

Tong Youzhi

Executive

Other

Kintor Pharmaceutical Ltd. - B

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

CEO

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the complete record of transactions filed by Tong Youzhi, Executive. Director active across 1 company, notably Kintor Pharmaceutical Ltd. - B. Aggregated, 20 reports have been published. History available since 2 April 2026. The latest transaction was filed on 17 July 2026 (Purchase). Regulator: HKEX. All data is openly available.

Companies and markets linked to Tong Youzhi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Kintor Pharmaceutical Ltd. - B (HK)

Declarations20 total

●

DirectorExecutives17 Jul 2026Kintor Pharmaceutical Ltd. - B

HK$248,3850HKEX ↗

145,000 shares@ HK$1.713ShareXHKGHKEX:DA20260721E00089

●

DirectorExecutives25 Jun 2026Kintor Pharmaceutical Ltd. - B

HK$515,50016HKEX ↗

250,000 shares@ HK$2.0620.059% mcap0.9% of flowShareXHKGHKEX:DA20260626E00073

●

DirectorExecutives9 Jun 2026Kintor Pharmaceutical Ltd. - B

HK$182,70011HKEX ↗

75,000 shares@ HK$2.4360.0021% mcap0.3% of flowShareXHKGHKEX:DA20260611E00155

●

DirectorExecutives5 Jun 2026Kintor Pharmaceutical Ltd. - B

HK$314,75011HKEX ↗

125,000 shares@ HK$2.5180.0036% mcap0.5% of flowShareXHKGHKEX:DA20260608E00336

●

DirectorExecutives4 Jun 2026Kintor Pharmaceutical Ltd. - B

HK$130,00011HKEX ↗

50,000 shares@ HK$2.600.0015% mcap0.2% of flowShareXHKGHKEX:DA20260608E00319

●

DirectorExecutives28 May 2026Kintor Pharmaceutical Ltd. - B

HK$423,70011HKEX ↗

190,000 shares@ HK$2.230.0048% mcap0.7% of flowShareXHKGHKEX:DA20260528E00212

●

DirectorExecutives26 May 2026Kintor Pharmaceutical Ltd. - B

HK$272,25011HKEX ↗

110,000 shares@ HK$2.4750.0031% mcap0.5% of flowShareXHKGHKEX:DA20260528E00199

●

DirectorExecutives27 May 2026Kintor Pharmaceutical Ltd. - B

HK$97,86011HKEX ↗

42,000 shares@ HK$2.330.0011% mcap0.2% of flowShareXHKGHKEX:DA20260528E00204

●

DirectorExecutives21 May 2026Kintor Pharmaceutical Ltd. - B

HK$100,32011HKEX ↗

38,000 shares@ HK$2.640.0011% mcap0.2% of flowShareXHKGHKEX:DA20260522E00299

●

DirectorExecutives19 May 2026Kintor Pharmaceutical Ltd. - B

HK$191,80022HKEX ↗

70,000 shares@ HK$2.740.18% mcap27.1% of flowShareXHKGHKEX:DA20260520E00152

●

DirectorExecutives18 May 2026Kintor Pharmaceutical Ltd. - B

HK$476,00028HKEX ↗

170,000 shares@ HK$2.800.45% mcap67.6% of flowShareXHKGHKEX:DA20260519E00135

●

DirectorExecutives8 May 2026Kintor Pharmaceutical Ltd. - B

HK$229,60014HKEX ↗

80,000 shares@ HK$2.870.023% mcap0.4% of flowShareXHKGHKEX:DA20260511E00237

●

Executives24 Apr 2026Kintor Pharmaceutical Ltd. - B

HK$73,8083HKEX ↗

28,000 shares@ HK$2.6360.0075% mcap0.1% of flowShareXHKGHKEX:DA20260427E00032

●

Executives21 Apr 2026Kintor Pharmaceutical Ltd. - B

HK$130,4644HKEX ↗

48,000 shares@ HK$2.7180.013% mcap0.2% of flowShareXHKGHKEX:DA20260422E00263

●

Executives17 Apr 2026Kintor Pharmaceutical Ltd. - B

HK$27,4702HKEX ↗

10,000 shares@ HK$2.7470.0028% mcap0.0% of flowShareXHKGHKEX:DA20260420E00094

●

Executives16 Apr 2026Kintor Pharmaceutical Ltd. - B

HK$798,9508HKEX ↗

290,000 shares@ HK$2.7550.080% mcap1.3% of flowShareXHKGHKEX:DA20260417E00334

●

Executives9 Apr 2026Kintor Pharmaceutical Ltd. - B

HK$132,0003HKEX ↗

50,000 shares@ HK$2.640.0016% mcap7.5% of flowShareXHKGHKEX:DA20260410E00214

●

Executives8 Apr 2026Kintor Pharmaceutical Ltd. - B

HK$175,5003HKEX ↗

65,000 shares@ HK$2.700.0021% mcap10.1% of flowShareXHKGHKEX:DA20260409E00109

●

Executives2 Apr 2026Kintor Pharmaceutical Ltd. - B

HK$185,4713HKEX ↗

71,500 shares@ HK$2.5940.0022% mcap10.7% of flowShareXHKGHKEX:DA20260407E00049

●

Executives31 Mar 2026Kintor Pharmaceutical Ltd. - B

1,250,000 sharesShareXHKGHKEX:DA20260401E00085

20 of 20 declarations

About Tong Youzhi

Tong Youzhi is an executive at Kintor Pharmaceutical Ltd. - B, a company engaged in drug development. He plays a key role in managing operations and the company's growth strategy.